Erratum: Dynamics of SIV-specific CXCR5+ CD8 T cells during chronic SIV infection (Proceedings of the National Academy of Sciences of the United States of America (2017) 114 (1976-1981) DOI: 10.1073/pnas.1621418114);Dynamics of SIV-specific CXCR5+ CD8 T cells during chronic SIV infection

Proceedings of the National Academy of Sciences of the United States of America

Volumn 114, Issue 8, 2017, Pages 1976-1981

  Mylvaganam, Geetha H ^a,b   Rios, Daniel ^a   Abdelaal, Hadia M ^c,d   Iyer, Smita ^b   Tharp, Gregory ^b   Mavinger, Maud ^a   Hicks, Sakeenah ^b   Chahroudi, Ann ^a   Ahmed, Rafi ^a,b   Bosinger, Steven E ^b   Williams, Ifor R ^a   Skinner, Pamela J ^c   Velu, Vijayakumar ^b   Amara, Rama R ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d Zagazig University   (Egypt)

Author keywords

CXCR5+CD8+ T cells; Follicular CD8 T cells; HIV; Lymphoid follicles; SIV

Indexed keywords

CD8 ANTIGEN; CHEMOKINE RECEPTOR CXCR5; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 2; RANTES; SIMIAN IMMUNODEFICIENCY VIRUS VACCINE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOLYSIS; FLOW CYTOMETRY; GENE EXPRESSION; IN VITRO STUDY; IN VIVO STUDY; INFECTION CONTROL; LYMPHOCYTE HOMING; MICROARRAY ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VACCINATION; VIRUS PATHOGENESIS; ANIMAL; CHRONIC DISEASE; CYTOLOGY; GERMINAL CENTER; IMMUNOLOGY; MALE; METABOLISM; PHYSIOLOGY; RHESUS MONKEY;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CHRONIC DISEASE; GERMINAL CENTER; MACACA MULATTA; MALE; RECEPTORS, CXCR5; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 85013335909     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1703867114     Document Type: Erratum

References (39)

1. Matano T, et al. (1998) Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques. J Virol 72(1):164-169.
2. Schmitz JE, et al. (1999) Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 283(5403):857-860.
3. Jin X, et al. (1999) Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques. J Exp Med 189(6):991-998.
4. Borrow P, Lewicki H, Hahn BH, Shaw GM, Oldstone MB (1994) Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol 68(9):6103-6110.
5. Migueles SA, et al. (2002) HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat Immunol 3(11):1061-1068.
6. Betts MR, et al. (2006) HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 107(12):4781-4789.
7. Koup RA, et al. (1994) Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol 68(7):4650-4655.
8. Ndhlovu ZM, et al. (2015) Magnitude and kinetics of CD8+ T cell activation during hyperacute HIV infection impact viral set point. Immunity 43(3):591-604.
9. Barouch DH, et al. (2000) Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. Science 290(5491):486-492.
10. Amara RR, et al. (2001) Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Science 292(5514):69-74.
11. Liu J, et al. (2009) Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys. Nature 457(7225):87-91.
12. Hansen SG, et al. (2011) Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine. Nature 473(7348):523-527.
13. Pantaleo G, et al. (1991) Lymphoid organs function as major reservoirs for human immunodeficiency virus. Proc Natl Acad Sci USA 88(21):9838-9842.
14. Perreau M, et al. (2013) Follicular helper T cells serve as the major CD4 T cell compartment for HIV-1 infection, replication, and production. J Exp Med 210(1):143-156.
15. Mylvaganam GH, et al. (2014) Diminished viral control during simian immunodeficiency virus infection is associated with aberrant PD-1hi CD4 T cell enrichment in the lymphoid follicles of the rectal mucosa. J Immunol 193(9):4527-4536.
16. Connick E, et al. (2007) CTL fail to accumulate at sites of HIV-1 replication in lymphoid tissue. J Immunol 178(11):6975-6983.
17. Connick E, et al. (2014) Compartmentalization of simian immunodeficiency virus replication within secondary lymphoid tissues of rhesus macaques is linked to disease stage and inversely related to localization of virus-specific CTL. J Immunol 193(11):5613-5625.
18. Fukazawa Y, et al. (2015) B cell follicle sanctuary permits persistent productive simian immunodeficiency virus infection in elite controllers. Nat Med 21(2):132-139.
19. Förster R, et al. (1996) A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell 87(6):1037-1047.
20. Breitfeld D, et al. (2000) Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production. J Exp Med 192(11):1545-1552.
21. Leong YA, et al. (2016) CXCR5+ follicular cytotoxic T cells control viral infection in B cell follicles. Nat Immunol 17(10):1187-1196.
22. He R, et al. (2016) Follicular CXCR5-expressing CD8+ T cells curtail chronic viral infection. Nature 537(7620):412-428.
23. Im SJ, et al. (2016) Defining CD8(+) T cells that provide the proliferative burst after PD-1 therapy. Nature 537(7620):417-421.
24. Petrovas C, et al. (2012) CD4 T follicular helper cell dynamics during SIV infection. J Clin Invest 122(9):3281-3294.
25. Lindqvist M, et al. (2012) Expansion of HIV-specific T follicular helper cells in chronic HIV infection. J Clin Invest 122(9):3271-3280.
26. Hong JJ, Amancha PK, Rogers K, Ansari AA, Villinger F (2012) Spatial alterations between CD4(+) T follicular helper, B, and CD8(+) T cells during simian immunodeficiency virus infection: T/B cell homeostasis, activation, and potential mechanism for viral escape. J Immunol 188(7):3247-3256.
27. Velu V, et al. (2016) Induction of Th1-biased T follicular helper (Tfh) cells in lymphoid tissues during chronic simian immunodeficiency virus infection defines functionally distinct germinal center Tfh cells. J Immunol 197(5):1832-1842.
28. Quigley MF, Gonzalez VD, Granath A, Andersson J, Sandberg JK (2007) CXCR5+ CCR7-CD8 T cells are early effector memory cells that infiltrate tonsil B cell follicles. Eur J Immunol 37(12):3352-3362.
29. Kannanganat S, et al. (2007) Human immunodeficiency virus type 1 controllers but not noncontrollers maintain CD4 T cells coexpressing three cytokines. J Virol 81(21):12071-12076.
30. Yoshida K, et al. (2006) Bcl6 controls granzyme B expression in effector CD8+ T cells. Eur J Immunol 36(12):3146-3156.
31. Yang CY, et al. (2011) The transcriptional regulators Id2 and Id3 control the formation of distinct memory CD8+ T cell subsets. Nat Immunol 12(12):1221-1229.
32. Schmitt N, et al. (2014) The cytokine TGF-β co-opts signaling via STAT3-STAT4 to promote the differentiation of human TFH cells. Nat Immunol 15(9):856-865.
33. Ploquin MJ, et al. (2006) Distinct expression profiles of TGF-beta1 signaling mediators in pathogenic SIVmac and non-pathogenic SIVagm infections. Retrovirology 3:37.
34. Poli G, et al. (1991) Transforming growth factor beta suppresses human immunodeficiency virus expression and replication in infected cells of the monocyte/macrophage lineage. J Exp Med 173(3):589-597.
35. Committee on Care and Use of Laboratory Animals (1996) Guide for the Care and Use of Laboratory Animals (Natl Inst Health, Bethesda), DHHS Publ No (NIH) 85-23.
36. Kwa S, et al. (2015) CD40L-adjuvanted DNA/modified vaccinia virus Ankara simian immunodeficiency virus (SIV) vaccine enhances protection against neutralization-resistant mucosal SIV infection. J Virol 89(8):4690-4695.
37. Velu V, et al. (2009) Enhancing SIV-specific immunity in vivo by PD-1 blockade. Nature 458(7235):206-210.
38. Abdelaal HM, et al. (2015) Comparison of Vibratome and Compresstome sectioning of fresh primate lymphoid and genital tissues for in situ MHC-tetramer and immunofluorescence staining. Biol Proced Online 17(1):2.
39. Kline C, et al. (2013) Persistence of viral reservoirs in multiple tissues after antiretroviral therapy suppression in a macaque RT-SHIV model. PLoS One 8(12):e84275.